-
Estimated Impact of the Inflation Reduction Act on Out-of-Pocket Spend Among Medicare Part D Beneficiaries with Cancer
Mar 10, 2025, 14:00 PM -
The Trajectory of Ground Glass Nodule Patients in China: A Real-World Perspective
Mar 10, 2025, 14:00 PM -
Real-world Impact of Semaglutide, Liraglutide, and Tirzepatide on Weight Loss and Cardiometabolic Lab Measures: A Look into Drug Persistence and Reasons for Discontinuation (r/dc)
Mar 10, 2025, 14:00 PM -
Do Breakthrough Therapies Demonstrate Breakthrough Value to Payers? An Evaluation of US Hemophilia B Gene Therapy Access Policies
Mar 10, 2025, 14:00 PM -
Prognostic Model for Overall Survival in Colorectal Cancer Patients in the US: A Real World Data Study
Mar 10, 2025, 14:00 PM -
How is Patient Safety Addressed in Pharmacy Degree Programs in Brazil?
Mar 10, 2025, 14:00 PM -
Estimating the Burden of Illness and Healthcare Costs Among Incident Catheter Users: A Comparison of Intermittent and Indwelling Catheter Cohorts Across Spinal Cord Injury, Multiple Sclerosis, Spina Bifida, and Benign Prostatic Hyperplasia in the US
Mar 10, 2025, 14:00 PM -
Broadening the Evidence Base: Incorporating Environmental Considerations Into HTAs
Mar 10, 2025, 14:00 PM -
A Web-Based Application To Automate the Development of State-Transition Models in Oncology Using Published Survival Curves and Bayesian Calibration
Mar 10, 2025, 14:00 PM -
Barriers to Genetic Risk Factor Molecular Testing in CLL: An Analysis of Real-World Practice and Alignment with 2023 Guidelines in Germany
Mar 10, 2025, 14:00 PM -
Identifying Risk Factors of Flare(s) in Patients With SLE After Glucocorticoids (GC) Withdrawal (<7.5mg) across 1.5 Years
Mar 10, 2025, 14:00 PM -
A Model-Based Cost-Effectiveness Analysis of Anamorelin and Olanzapine in NSCLC Cachexia Treatment in Japan
Mar 10, 2025, 14:00 PM -
Social Listening: A Content Analysis of Social Media Discussions in Prader Willi Syndrome (PWS)
Mar 10, 2025, 14:00 PM -
Time to Access Trends of Pharmaceutical Products in EU4 and UK (2019-2021)
Mar 10, 2025, 14:00 PM -
Adapting Global Cost-Effectiveness Models for Low- and Middle-Income Countries: Key Learnings and Challenges Addressed
Mar 10, 2025, 14:00 PM -
Evaluating Generative AI in Replicating Health Economic Models: A Case Study on Ulcerative Colitis
Mar 10, 2025, 14:00 PM -
Healthcare Across Borders: Changes in Physician Numbers and Spatial Inequalities in Hungary and the DACH Countries (Austria, Germany, Switzerland)
Mar 10, 2025, 14:00 PM -
Assessing Risdiplam Cost-Effectiveness for Spinal Muscular Atrophy Types I, II, and III in Chile
Mar 10, 2025, 14:00 PM -
Use of Health Technology Assessments in Specialty Drug Coverage Decisions by U.S. Commercial Health Plans
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Pembrolizumab in 1L Recurrent/Metastatic Head and Neck Squamous Cell Cancer (R/M HNSCC) in Brazil
Mar 10, 2025, 14:00 PM
